Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) Shares Outstanding (Weighted Average) (2019 - 2024)

Historic Shares Outstanding (Weighted Average) for Volitionrx (VNRX) over the last 8 years, with Q3 2024 value amounting to $87.9 million.

  • Volitionrx's Shares Outstanding (Weighted Average) rose 1241.95% to $87.9 million in Q3 2024 from the same period last year, while for Jun 2024 it was $82.7 million, marking a year-over-year increase of 2360.04%. This contributed to the annual value of $71.2 million for FY2023, which is 2869.75% up from last year.
  • As of Q3 2024, Volitionrx's Shares Outstanding (Weighted Average) stood at $87.9 million, which was up 1241.95% from $82.7 million recorded in Q2 2024.
  • Volitionrx's 5-year Shares Outstanding (Weighted Average) high stood at $87.9 million for Q3 2024, and its period low was $41.2 million during Q1 2020.
  • For the 5-year period, Volitionrx's Shares Outstanding (Weighted Average) averaged around $60.5 million, with its median value being $54.6 million (2022).
  • In the last 5 years, Volitionrx's Shares Outstanding (Weighted Average) skyrocketed by 163.05% in 2022 and then soared by 3930.28% in 2023.
  • Quarter analysis of 5 years shows Volitionrx's Shares Outstanding (Weighted Average) stood at $47.0 million in 2020, then rose by 11.97% to $52.7 million in 2021, then increased by 5.12% to $55.4 million in 2022, then grew by 28.7% to $71.2 million in 2023, then rose by 23.38% to $87.9 million in 2024.
  • Its Shares Outstanding (Weighted Average) stands at $87.9 million for Q3 2024, versus $82.7 million for Q2 2024 and $82.0 million for Q1 2024.